Ardea Biosciences (RDEA), which closed the day with a market cap of $470.4M, has filed for a...

|About: Ardea Biosciences, Inc. (RDEA)|By:, SA News Editor

Ardea Biosciences (RDEA), which closed the day with a market cap of $470.4M, has filed for a $150M mixed shelf offering. The company plans to partly use the proceeds to help fund a clinical trial for its Lesinurad drug for treating gout.